Cargando…
Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia
OBJECTIVE: The current study aimed to explore the association of single nucleotide polymorphisms (SNPs) within catechol-O-methyltransferase (COMT) and dopamine receptors with schizophrenia and genetic association with risperidone treatment response. METHODS: A total of 690 schizophrenic patients (ca...
Autores principales: | Han, Jiyang, Li, Yan, Wang, Xumei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722007/ https://www.ncbi.nlm.nih.gov/pubmed/29255361 http://dx.doi.org/10.2147/NDT.S148824 |
Ejemplares similares
-
Genetics of headache and catechol–O–methyltransferase gene polymorphism
por: Bayazit, Yildirim A.
Publicado: (2006) -
Genetic Contribution of Catechol-O-methyltransferase Polymorphism in Patients with Migraine without Aura
por: Park, Jeong Wook, et al.
Publicado: (2007) -
Genetic Polymorphisms of Catechol-O-Methyltransferase Modify the Neurobehavioral Effects of Mercury in Children
por: Woods, James S., et al.
Publicado: (2014) -
Catechol-O-methyltransferase (COMT) polymorphisms modulate working memory in individuals with schizophrenia and healthy controls
por: Matsuzaka, Camila T., et al.
Publicado: (2017) -
Cannabis, Schizophrenia Risk and Genetics: A Case Report of a Patient With Homozygous Valine Catechol-O-Methyltransferase Polymorphism
por: Grechuk, Katelyn, et al.
Publicado: (2021)